MLN4924 injection improves high-fat diet (HFD)-induced glucose intolerance via inhibiting the neddylation of peroxisome proliferator-activated receptor gamma (PPARγ) in mouse models69. This evidence concerns the gene PPARG and Glucose intolerance.